Jeffrey Reed, MD
Dermatology · Saint Louis, MONPI 1205820362
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $109,068 of the $169,922 with a category attached, or 64.2%. Galderma Laboratories, L.p. accounts for 82.8% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2023 at $46,040 and has fallen 75.6% since, to $11,214 in 2025. Among dermatology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,679 payments — averaging $101.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$141K
- Journey Medical Corporation$5K
- UCB, Inc.$4K
- AbbVie$4K
- Johnson & Johnson$2K
- Novartis$2K
- plus $12K from 34 others
Across 3 payments — averaging $762.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Almirall LLC$2K
What the payments were for
- Consulting fees$12,0007%
- Speaking & faculty fees$109,06864%
- Travel & lodging$5,8823%
- Food & beverage$42,41925%
- Education$5530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$169,922 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 130 | $4,403 |
| Imiquimod | 96 | $3,351 |
| Clobetasol Propionate | 65 | $3,238 |
| Metronidazole | 51 | $2,542 |
| Clindamycin Phosphate | 50 | $1,828 |
| Triamcinolone Acetonide | 204 | $1,702 |
| Betamethasone Dipropionate | 45 | $1,668 |
| Hydrocortisone | 99 | $909 |
| ValacyclovirValacyclovir Hcl | 31 | $624 |
| Ketoconazole | 49 | $517 |
| Econazole Nitrate | 25 | $429 |
| Minocycline Hcl | 28 | $397 |
| Mupirocin | 30 | $283 |
| Spironolactone | 17 | $236 |
| Famciclovir | 15 | $236 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Saint Louis
- Brian KimSaint Louis$861K
- Elaine SiegfriedSaint Louis$856K
- Craig LeonardiSaint Louis$569K
- Mary GeorgeSaint Louis$400K
- Duane DilworthSaint Louis$288K
- Emily ColeSaint Louis$163K
- Dee GlaserSaint Louis$131K
- Milan AnadkatSaint Louis$129K
- Jason AmatoSaint Louis$45K
- Amy MusiekSaint Louis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.